nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—PTGS1—Ifosfamide—testicular cancer	0.266	0.382	CbGbCtD
Icosapent—PTGS2—Cisplatin—testicular cancer	0.153	0.22	CbGbCtD
Icosapent—PTGS2—Etoposide—testicular cancer	0.15	0.216	CbGbCtD
Icosapent—PTGS1—Etoposide—testicular cancer	0.127	0.182	CbGbCtD
Icosapent—SLC8A1—embryo—testicular cancer	0.0269	0.0983	CbGeAlD
Icosapent—ACSL3—gonad—testicular cancer	0.0221	0.0805	CbGeAlD
Icosapent—FABP7—embryo—testicular cancer	0.0198	0.0723	CbGeAlD
Icosapent—ACSL3—female gonad—testicular cancer	0.0179	0.0654	CbGeAlD
Icosapent—FADS1—seminal vesicle—testicular cancer	0.0169	0.0616	CbGeAlD
Icosapent—ACSL3—testis—testicular cancer	0.0159	0.058	CbGeAlD
Icosapent—ACSL4—seminal vesicle—testicular cancer	0.0153	0.0559	CbGeAlD
Icosapent—TRPV1—gonad—testicular cancer	0.0122	0.0445	CbGeAlD
Icosapent—ACSL4—gonad—testicular cancer	0.0111	0.0404	CbGeAlD
Icosapent—PPARG—Teniposide—Etoposide—testicular cancer	0.00991	1	CbGdCrCtD
Icosapent—FADS1—female gonad—testicular cancer	0.00991	0.0362	CbGeAlD
Icosapent—ACSL4—female gonad—testicular cancer	0.009	0.0328	CbGeAlD
Icosapent—FADS1—testis—testicular cancer	0.00879	0.0321	CbGeAlD
Icosapent—TRPV1—testis—testicular cancer	0.00879	0.0321	CbGeAlD
Icosapent—PPARD—female gonad—testicular cancer	0.00864	0.0315	CbGeAlD
Icosapent—ACSL4—testis—testicular cancer	0.00798	0.0291	CbGeAlD
Icosapent—PPARD—testis—testicular cancer	0.00766	0.028	CbGeAlD
Icosapent—PPARG—embryo—testicular cancer	0.00734	0.0268	CbGeAlD
Icosapent—FADS1—lymph node—testicular cancer	0.00637	0.0233	CbGeAlD
Icosapent—ACSL4—lymph node—testicular cancer	0.00578	0.0211	CbGeAlD
Icosapent—PPARD—lymph node—testicular cancer	0.00555	0.0203	CbGeAlD
Icosapent—PPARG—female gonad—testicular cancer	0.00405	0.0148	CbGeAlD
Icosapent—PTGS2—embryo—testicular cancer	0.00375	0.0137	CbGeAlD
Icosapent—PTGS1—seminal vesicle—testicular cancer	0.00368	0.0135	CbGeAlD
Icosapent—PPARG—testis—testicular cancer	0.00359	0.0131	CbGeAlD
Icosapent—PTGS2—seminal vesicle—testicular cancer	0.00352	0.0129	CbGeAlD
Icosapent—PPARG—lymph node—testicular cancer	0.0026	0.0095	CbGeAlD
Icosapent—PTGS1—female gonad—testicular cancer	0.00216	0.0079	CbGeAlD
Icosapent—PTGS2—female gonad—testicular cancer	0.00207	0.00755	CbGeAlD
Icosapent—PTGS1—testis—testicular cancer	0.00192	0.00701	CbGeAlD
Icosapent—PPARD—Ectoderm Differentiation—TFAP2C—testicular cancer	0.00168	0.0862	CbGpPWpGaD
Icosapent—SLC8A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00152	0.078	CbGpPWpGaD
Icosapent—PPARD—NRF2 pathway—SLC2A6—testicular cancer	0.00147	0.0753	CbGpPWpGaD
Icosapent—PTGS1—lymph node—testicular cancer	0.00139	0.00508	CbGeAlD
Icosapent—PTGS2—lymph node—testicular cancer	0.00133	0.00485	CbGeAlD
Icosapent—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00133	0.0683	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00118	0.0604	CbGpPWpGaD
Icosapent—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00106	0.0542	CbGpPWpGaD
Icosapent—FFAR1—Integration of energy metabolism—STK11—testicular cancer	0.000903	0.0464	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—INSL3—testicular cancer	0.000895	0.046	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000772	0.0396	CbGpPWpGaD
Icosapent—TRPV1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000745	0.0383	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—INSL3—testicular cancer	0.000506	0.026	CbGpPWpGaD
Icosapent—PTGS1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00048	0.0247	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—INSL3—testicular cancer	0.000459	0.0236	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000421	0.0216	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000407	0.0209	CbGpPWpGaD
Icosapent—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000381	0.0196	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—PRDM14—testicular cancer	0.000371	0.019	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000353	0.0181	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000319	0.0164	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—INSL3—testicular cancer	0.000271	0.0139	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000264	0.0135	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—DNMT3L—testicular cancer	0.000214	0.011	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—HPGDS—testicular cancer	0.000188	0.00963	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000184	0.00944	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000179	0.00921	CbGpPWpGaD
Icosapent—PTGS1—Biological oxidations—HPGDS—testicular cancer	0.000179	0.00917	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	0.000169	0.00869	CbGpPWpGaD
Icosapent—FADS1—Metabolism—HPGDS—testicular cancer	0.000157	0.00807	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—HPGDS—testicular cancer	0.000142	0.0073	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—HPGDS—testicular cancer	0.000142	0.0073	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—STK11—testicular cancer	0.000136	0.007	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.00013	0.0067	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—DNMT3L—testicular cancer	0.000117	0.00601	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	0.000115	0.00593	CbGpPWpGaD
Icosapent—FADS1—Metabolism—STK11—testicular cancer	0.000114	0.00586	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—MMP2—testicular cancer	0.000112	0.00576	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—STK11—testicular cancer	0.000103	0.0053	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—STK11—testicular cancer	0.000103	0.0053	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	9.79e-05	0.00503	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	9.48e-05	0.00487	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—H2AFZ—testicular cancer	8.68e-05	0.00446	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—STK11—testicular cancer	8.63e-05	0.00443	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KITLG—testicular cancer	7.99e-05	0.0041	CbGpPWpGaD
Icosapent—PPARD—Metabolism—HPGDS—testicular cancer	7.99e-05	0.0041	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—H2AFZ—testicular cancer	7.51e-05	0.00386	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.86e-05	0.00352	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—FGFR3—testicular cancer	5.94e-05	0.00305	CbGpPWpGaD
Icosapent—PPARD—Metabolism—STK11—testicular cancer	5.8e-05	0.00298	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KIT—testicular cancer	5.45e-05	0.0028	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.45e-05	0.0028	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP2—testicular cancer	4.46e-05	0.00229	CbGpPWpGaD
Icosapent—PPARG—Metabolism—HPGDS—testicular cancer	4.36e-05	0.00224	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—H2AFZ—testicular cancer	4.1e-05	0.00211	CbGpPWpGaD
Icosapent—PPARG—Metabolism—STK11—testicular cancer	3.17e-05	0.00163	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HPGDS—testicular cancer	3.06e-05	0.00157	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HPGDS—testicular cancer	2.43e-05	0.00125	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—STK11—testicular cancer	2.22e-05	0.00114	CbGpPWpGaD
Icosapent—PTGS2—Disease—H2AFZ—testicular cancer	2.12e-05	0.00109	CbGpPWpGaD
Icosapent—PTGS2—Disease—KITLG—testicular cancer	1.95e-05	0.001	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—STK11—testicular cancer	1.76e-05	0.000905	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGFR3—testicular cancer	1.45e-05	0.000743	CbGpPWpGaD
Icosapent—PTGS2—Disease—KIT—testicular cancer	1.33e-05	0.000682	CbGpPWpGaD
